Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes - PubMed (original) (raw)
Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes
C Vaquero et al. J Interferon Res. 1986 Apr.
Abstract
Two interferon (IFN) messengers were synthesized in phytohemagglutinin (PHA)-activated lymphocytes: IFN-gamma mRNA and a messenger hybridizing with the IFN-beta 2 probe. They were induced rapidly and declined at a stage when overall RNA was still efficiently transcribed. The IFN-beta 2 mRNA (15S) present in the lymphocytes was slightly different from its fibroblastic counterpart (14S). The kinetics of the accumulation and decay of both lymphocyte IFN messengers differed when assessed by hybridization with the two IFN probes, IFN-gamma mRNA was not detected before mitogenic activation and accumulated for up to 15 h postactivation, while IFN-beta 2 mRNA accumulated even in the absence of PHA activation for up to 5 h, even though the activation raised the IFN-beta 2 mRNA level at 5 h. The disappearance of IFN messengers was prevented when cycloheximide was added 5 h after PHA activation, when the transcription of both messengers had already been turned on, suggesting the presence of the repressor mechanism proposed for IFN-beta 1 and IFN-beta 2 mRNAs in fibroblasts. In the absence of PHA activation, cycloheximide did not induce IFN-beta 2 mRNA transcription as it did in fibroblasts and moreover prevented the accumulation of the messenger observed in the control cells. In contrast to IFN-beta 2 mRNA, cycloheximide treatment of lymphocytes produced a slight accumulation of IFN-gamma mRNA. This accumulation was already detectable 6 h posttreatment and its level remained unchanged for up to 24 h. Addition of actinomycin D, 5 h after PHA activation, did not impair the shut off and accelerated the decay of IFN messengers.
Similar articles
- Translation of mRNA from phytohemagglutinin-stimulated human lymphocytes: characterization of interferon mRNAs.
Vaquero C, Sancéau J, Catinot L, Andreu G, Falcoff E, Falcoff R. Vaquero C, et al. J Interferon Res. 1982;2(2):217-28. doi: 10.1089/jir.1982.2.217. J Interferon Res. 1982. PMID: 6126511 - The defective in vitro expression of interferon-gamma messenger RNA in rheumatoid arthritis is recovered by cycloheximide.
Sadouk MB, Rajzbaum G, Vaquero C, Amor B, Toubert A. Sadouk MB, et al. Cell Immunol. 1991 Oct 1;137(1):239-44. doi: 10.1016/0008-8749(91)90073-k. Cell Immunol. 1991. PMID: 1909216 - Interferon gamma mRNA "superinduction" in human lymphocytes.
Siggens KW, Morris AG. Siggens KW, et al. Biochem Biophys Res Commun. 1985 Nov 27;133(1):274-9. doi: 10.1016/0006-291x(85)91871-6. Biochem Biophys Res Commun. 1985. PMID: 3935113 - Direct induction of interferon-gamma- and interferon-alpha/beta-inducible genes by double-stranded RNA.
Mémet S, Besançon F, Bourgeade MF, Thang MN. Mémet S, et al. J Interferon Res. 1991 Jun;11(3):131-41. doi: 10.1089/jir.1991.11.131. J Interferon Res. 1991. PMID: 1919073
Cited by
- Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene.
Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, Kishimoto T. Yasukawa K, et al. EMBO J. 1987 Oct;6(10):2939-45. doi: 10.1002/j.1460-2075.1987.tb02598.x. EMBO J. 1987. PMID: 3500852 Free PMC article. - B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.
Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA. Lotz M, et al. J Exp Med. 1988 Mar 1;167(3):1253-8. doi: 10.1084/jem.167.3.1253. J Exp Med. 1988. PMID: 3127525 Free PMC article. - Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.
Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Gauldie J, et al. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251-5. doi: 10.1073/pnas.84.20.7251. Proc Natl Acad Sci U S A. 1987. PMID: 2444978 Free PMC article. - Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.
Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Van Snick J. Van Damme J, et al. J Exp Med. 1987 Mar 1;165(3):914-9. doi: 10.1084/jem.165.3.914. J Exp Med. 1987. PMID: 3493322 Free PMC article. - Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes.
Cheung DL, Hart PH, Vitti GF, Whitty GA, Hamilton JA. Cheung DL, et al. Immunology. 1990 Sep;71(1):70-5. Immunology. 1990. PMID: 2120129 Free PMC article.